Christine Etherington
Overview
Explore the profile of Christine Etherington including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
261
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jarosz-Griffiths H, Gillgrass L, Caley L, Spoletini G, Clifton I, Etherington C, et al.
PLoS One
. 2024 May;
19(5):e0304555.
PMID: 38820269
Inflammation is a key driver in the pathogenesis of cystic fibrosis (CF). We assessed the effectiveness of elexacaftor/tezacaftor/ivacaftor (ETI) therapy on downregulating systemic and immune cell-derived inflammatory cytokines. We also...
2.
Spoletini G, Fitch G, Gillgrass L, Etherington C, Clifton I, Peckham D
ERJ Open Res
. 2022 May;
8(2).
PMID: 35539439
https://bit.ly/3NFPkUu.
3.
Spoletini G, Watson R, Lim W, Pollard K, Etherington C, Clifton I, et al.
J Cyst Fibros
. 2021 Apr;
20(5):e46-e52.
PMID: 33814320
Background: Exercise tolerance in people with CF and advanced lung disease is often reduced. While supplemental oxygen can improve oxygenation, it does not affect dyspnoea, fatigue or comfort. Nasal high-flow...
4.
Spoletini G, Pollard K, Watson R, Darby M, Johnstone A, Etherington C, et al.
Respir Care
. 2020 Sep;
66(3):466-474.
PMID: 32900912
Background: Noninvasive ventilation (NIV) is routinely used to treat patients with cystic fibrosis and respiratory failure. However, evidence on its use is limited, with no data on its role in...
5.
Jarosz-Griffiths H, Scambler T, Wong C, Lara-Reyna S, Holbrook J, Martinon F, et al.
Elife
. 2020 Mar;
9.
PMID: 32118580
Previously, we showed that serum and monocytes from patients with CF exhibit an enhanced NLRP3-inflammasome signature with increased IL-18, IL-1β, caspase-1 activity and ASC speck release (Scambler et al. eLife...
6.
Sawant A, Spoletini G, Whitaker P, Etherington C, Clifton I, Peckham D
ERJ Open Res
. 2018 Jan;
4(1).
PMID: 29333432
http://ow.ly/Rdds30hlnjV.
7.
Cammidge S, Duff A, Latchford G, Etherington C
Pulm Med
. 2016 Dec;
2016:9458980.
PMID: 27999682
Advances in the treatment and life expectancy of cystic fibrosis (CF) patients mean that motherhood is now a realistic option for many women with CF. This qualitative study explored the...
8.
Shah A, Connelly M, Whitaker P, McIntyre C, Etherington C, Denton M, et al.
Eur Respir J
. 2015 May;
45(6):1748-51.
PMID: 25976682
No abstract available.
9.
Whitaker P, Brownlee K, Lee T, Conway S, Etherington C, Peckham D
J Bronchology Interv Pulmonol
. 2012 Nov;
18(1):57-60.
PMID: 23169021
Lobar atelectasis is a common complication in patients with cystic fibrosis. Failure to reexpand the lung isassociated with poorer outcomes. We report sequential weekly flexible bronchoscopy, with instillation of recombinant...
10.
Cargill J, Etherington C, Peckham D, Conway S, Denton M
J Cyst Fibros
. 2012 Mar;
11(4):337-9.
PMID: 22414533
Background: We report the aetiology and outcome of bloodstream infections (BSI) occurring at two regional cystic fibrosis (CF) centres (one adult, one paediatric) between 1998 and 2006. Methods: A retrospective...